These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 33180345)

  • 21. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients.
    Ben M'rad M; Leclerc-Mercier S; Blanche P; Franck N; Rozenberg F; Fulla Y; Guesmi M; Rollot F; Dehoux M; Guillevin L; Moachon L
    Medicine (Baltimore); 2009 May; 88(3):131-140. PubMed ID: 19440116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
    Matsuda H; Saito K; Takayanagi Y; Okazaki T; Kashima K; Ishikawa K; Kai Y; Takeo N; Hatano Y; Okamoto O; Fujiwara S
    J Dermatol; 2013 Feb; 40(2):118-22. PubMed ID: 23216243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome.
    Morita C; Yanase T; Shiohara T; Aoyama Y
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30368475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses.
    Mitani N; Aihara M; Yamakawa Y; Yamada M; Itoh N; Mizuki N; Ikezawa Z
    J Med Virol; 2005 Mar; 75(3):430-4. PubMed ID: 15648066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-Induced Hypersensitivity Syndrome Followed by Subacute Thyroiditis.
    Sato M; Mizuno Y; Matsuyama K; Shu E; Kanoh H; Suwa T; Seishima M
    Case Rep Dermatol; 2015; 7(2):161-5. PubMed ID: 26351424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lamotrigine induced hypersensitivity syndrome in children: a case report].
    Cui NX; Zhu XP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 51(2):356-358. PubMed ID: 30996382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late-onset interstitial nephritis in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Higashi Y; Baba N; Yoshimine H; Sakaguchi I; Kanekura T
    J Dermatol; 2020 Feb; 47(2):174-177. PubMed ID: 31840853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms following nivolumab and ipilimumab in a pediatric patient with melanoma.
    Aljundi N; Utz Petry S; Moossavi M; Daveluy S
    Pediatr Dermatol; 2022 May; 39(3):486-487. PubMed ID: 35797209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019.
    Shiohara T; Mizukawa Y
    Allergol Int; 2019 Jul; 68(3):301-308. PubMed ID: 31000444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
    Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H
    J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facial pustules due to drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms may histopathologically mimic eosinophilic pustular folliculitis: A case report.
    Ogawa K; Mitsui Y; Miyamoto S; Nakamura-Nishimura Y; Nakanishi Y; Azukizawa H; Asada H
    J Cutan Pathol; 2019 May; 46(5):363-367. PubMed ID: 30666704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review.
    Gentile I; Talamo M; Borgia G
    BMC Infect Dis; 2010 Mar; 10():49. PubMed ID: 20205923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Case of Vancomycin-Induced Drug Reaction with Eosinophilia, Systemic Symptoms and Multiorgan Involvement Proven Using Lymphocyte Transformation Test.
    Chung KB; Hwang JH; Kim D
    Ann Dermatol; 2023 Apr; 35(2):140-145. PubMed ID: 37041708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
    Takehara A; Aoyama Y; Kurosawa M; Shirafuji Y; Umemura H; Kamiya K; Ushigome Y; Kano Y; Shiohara T; Iwatsuki K
    Br J Dermatol; 2016 Nov; 175(5):944-952. PubMed ID: 27087170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease.
    Mizukawa Y; Hirahara K; Kano Y; Shiohara T
    J Am Acad Dermatol; 2019 Mar; 80(3):670-678.e2. PubMed ID: 30240780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
    Avancini J; Maragno L; Santi CG; Criado PR
    Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
    Watanabe H
    J Immunol Res; 2018; 2018():5163129. PubMed ID: 29744372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin-associated drug-induced hypersensitivity syndrome.
    Madigan LM; Fox LP
    J Am Acad Dermatol; 2019 Jul; 81(1):123-128. PubMed ID: 30738120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occupational trichloroethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes.
    Kamijima M; Wang H; Yamanoshita O; Ito Y; Xia L; Yanagiba Y; Chen C; Okamura A; Huang Z; Qiu X; Song X; Cai T; Liu L; Ge Y; Deng Y; Naito H; Yoshikawa T; Tohyama M; Li L; Huang H; Nakajima T
    J Dermatol Sci; 2013 Dec; 72(3):218-24. PubMed ID: 23928230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfasalazine-induced hypersensitivity syndrome in a 15-year-old boy associated with human herpesvirus-6 reactivation.
    Balci DD; Peker E; Duran N; Dogramaci CA
    Cutan Ocul Toxicol; 2009; 28(1):45-7. PubMed ID: 19514926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.